Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
beta-Adrenergic Blocker [EPC]
Atenolol is a cardioselective beta-1 adrenergic antagonist used primarily to treat hypertension, angina pectoris, and to improve survival after a myocardial infarction. It belongs to the class of medications known as beta-blockers.
Name
Atenolol
Raw Name
ATENOLOL
Category
beta-Adrenergic Blocker [EPC]
Drug Count
5
Variant Count
135
Last Verified
February 17, 2026
RxCUI
197382, 197383, 197381, 197379, 197380, 150750, 152414, 201322, 746023, 746030
UNII
50VV3VW0TI, Q0MQD1073Q
About Atenolol
Atenolol is a cardioselective beta-1 adrenergic antagonist used primarily to treat hypertension, angina pectoris, and to improve survival after a myocardial infarction. It belongs to the class of medications known as beta-blockers.
Detailed information about Atenolol
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Atenolol.
Historically, Atenolol was one of the most widely prescribed antihypertensive agents in the world. Its long duration of action allows for once-daily dosing, which significantly improves patient adherence compared to older, multi-dose regimens. It is categorized as a hydrophilic (water-soluble) beta-blocker, which has profound implications for its clinical profile. Because it does not easily cross the blood-brain barrier, it is associated with a lower incidence of central nervous system side effects, such as vivid dreams or hallucinations, compared to lipophilic (fat-soluble) agents like metoprolol or propranolol. Your healthcare provider may prescribe Atenolol to manage chronic conditions or as part of a post-emergency treatment plan following a heart attack.
At the molecular level, Atenolol acts as a competitive antagonist at the beta-1 adrenergic receptors. To understand this, imagine the heart has 'keyholes' (receptors) that accept 'keys' (hormones like adrenaline). When adrenaline binds to these receptors, it triggers a cascade of events: the heart beats faster, it contracts with more force, and the blood vessels may constrict. Atenolol acts as a 'dummy key' that fits into the keyhole but doesn't turn the lock. By occupying these receptors, it prevents the body's natural adrenaline from stimulating the heart.
The clinical result of this blockade is a decrease in the 'workload' of the heart. By slowing the heart rate (negative chronotropic effect) and reducing the force of contraction (negative inotropic effect), the heart requires less oxygen to function. This is particularly beneficial for patients with angina, where the heart muscle isn't receiving enough oxygenated blood. Furthermore, by reducing the overall cardiac output and inhibiting the release of renin (an enzyme from the kidneys that increases blood pressure), Atenolol effectively lowers systemic blood pressure. It is important to note that Atenolol does not have intrinsic sympathomimetic activity (ISA), meaning it does not provide any partial stimulation to the receptor; it is a pure blocker.
Understanding how the body processes Atenolol is crucial for determining its safety and efficacy. The pharmacokinetic profile of Atenolol is distinct due to its hydrophilic nature.
Atenolol is FDA-approved for several critical cardiovascular indications:
Off-label uses (uses not specifically FDA-approved but supported by clinical practice) include the management of performance anxiety, prophylaxis of migraine headaches, and controlling the physical symptoms (tachycardia/tremors) associated with hyperthyroidism (Graves' disease).
Atenolol is primarily available in the following forms:
> Important: Only your healthcare provider can determine if Atenolol is right for your specific condition. Never start or stop this medication without professional medical advice.
The dosage of Atenolol must be individualized based on the patient's clinical response and the condition being treated.
Atenolol is not currently FDA-approved for use in pediatric patients. While some specialists may prescribe it 'off-label' for children with specific heart conditions or hypertension, the safety and effectiveness have not been established in clinical trials for this population. Pediatric dosing, if used, is strictly calculated based on the child's weight (mg/kg) by a pediatric cardiologist.
Since Atenolol is primarily excreted by the kidneys, dose adjustments are mandatory for patients with significant renal dysfunction.
No dosage adjustment is typically required for patients with liver disease, as Atenolol is not significantly metabolized by the liver.
Elderly patients should start at the lower end of the dosing range (e.g., 25 mg). This is because older adults are more likely to have decreased renal function and may be more sensitive to the drug's effects on heart rate and blood pressure.
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose (within 8 hours), skip the missed dose and resume your regular schedule. Never take two doses at once to 'catch up,' as this can lead to a dangerous drop in heart rate or blood pressure.
An overdose of Atenolol is a medical emergency. Symptoms include extreme bradycardia (very slow heart rate), severe hypotension (low blood pressure), heart failure, and bronchospasm (difficulty breathing).
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking the medication without medical guidance, as sudden discontinuation can be dangerous.
Atenolol is generally well-tolerated, but because it slows down certain bodily processes, some side effects are common. These often diminish as your body adjusts to the medication.
> Warning: Stop taking Atenolol and call your doctor immediately or seek emergency care if you experience any of the following:
With prolonged use, Atenolol may affect metabolic processes. It can sometimes mask the symptoms of hyperthyroidism or, more critically, the symptoms of low blood sugar (hypoglycemia) in diabetic patients. Long-term use can also lead to a slight increase in triglycerides and a decrease in 'good' HDL cholesterol. However, for most patients, the cardiovascular benefits of preventing heart attacks and strokes far outweigh these metabolic risks. Regular blood work and clinical monitoring are essential for those on long-term therapy.
Atenolol carries a critical warning regarding the sudden cessation of therapy. In patients with coronary artery disease, stopping Atenolol abruptly can lead to a severe worsening of angina, heart attack (myocardial infarction), or even ventricular arrhythmias. When discontinuing Atenolol, the dose must be gradually tapered over a period of 1 to 2 weeks under strict medical supervision. If angina worsens during the tapering process, the medication should be temporarily reinstated.
Report any unusual or persistent symptoms to your healthcare provider immediately to ensure your treatment remains safe and effective.
Atenolol is a potent medication that requires careful management. It is vital to understand that this drug does not 'cure' high blood pressure or heart disease; rather, it manages the symptoms and reduces the risk of complications. Patients must remain under regular medical supervision to monitor the drug's effects on the heart and kidneys. You should never share this medication with others, even if they have similar symptoms.
Full Text Summary: The FDA requires a boxed warning for Atenolol regarding the risk of abrupt withdrawal. Patients with underlying coronary artery disease (CAD) who suddenly stop taking Atenolol may experience a sharp increase in chest pain (angina), heart attacks, or sudden death. Because CAD is often undiagnosed, this warning applies to all patients. If you need to stop taking Atenolol, your doctor will provide a schedule to slowly decrease the dose over 7 to 14 days. During this time, you should limit physical activity to reduce the strain on your heart.
Your healthcare provider will likely require the following tests periodically:
Atenolol may cause dizziness, fatigue, or blurred vision, especially when you first start taking it or when the dose is increased. Do not drive or operate heavy machinery until you know how the medication affects you. If you feel lightheaded, sit or lie down immediately.
Alcohol can enhance the blood-pressure-lowering effects of Atenolol, which may lead to excessive dizziness or fainting. It is generally recommended to limit or avoid alcohol consumption while taking beta-blockers to prevent these additive effects.
As noted in the Black Box Warning, never stop Atenolol suddenly. Withdrawal symptoms can include severe headaches, sweating, palpitations, and a dangerous spike in blood pressure. Always follow a physician-led tapering schedule.
> Important: Discuss all your medical conditions, including any history of breathing problems or circulation issues, with your healthcare provider before starting Atenolol.
Certain medications should never be combined with Atenolol due to the risk of life-threatening complications:
Atenolol is not known to interfere significantly with most common laboratory tests. However, it may affect the results of a 'stress test' (exercise tolerance test) because it prevents the heart rate from rising normally during physical exertion. Inform your technician if you are taking Atenolol before undergoing any cardiac testing.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete list helps prevent dangerous interactions.
Atenolol must NEVER be used in patients with the following conditions:
In these cases, a doctor will perform a careful risk-benefit analysis:
Patients who have had a severe allergic reaction to other beta-blockers (such as metoprolol, nadolol, or propranolol) may also react to Atenolol. While not always the case, caution is warranted when switching between medications in the same class.
> Important: Your healthcare provider will evaluate your complete medical history and perform an EKG if necessary before prescribing Atenolol to ensure it is safe for your heart's specific electrical profile.
FDA Pregnancy Category D: There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience. Atenolol crosses the placental barrier and has been associated with fetal growth restriction (small for gestational age) and decreased placental weight. If taken during pregnancy, especially in the second and third trimesters, the newborn may be at risk for bradycardia (slow heart rate) and hypoglycemia (low blood sugar) at birth. Atenolol should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. Your doctor may prefer alternative antihypertensive agents like labetalol or methyldopa.
Atenolol is excreted in human breast milk in significant concentrations (the milk-to-plasma ratio is approximately 3:1). Infants who are breastfed by mothers taking Atenolol may develop symptoms of beta-blockade, such as a slow heart rate or difficulty breathing. If you are breastfeeding, your healthcare provider will help you weigh the risks. In many cases, close monitoring of the infant is required, or an alternative medication with lower excretion into milk may be chosen.
Safety and effectiveness in children have not been established. Use in pediatric populations is considered 'off-label.' If prescribed by a specialist, the child must be monitored closely for effects on growth, heart rate, and exercise tolerance. It is generally avoided in children with a history of asthma.
Clinical studies have shown that elderly patients may require lower doses of Atenolol. This is primarily because renal function naturally declines with age, and Atenolol is cleared by the kidneys. Older adults are also at a higher risk for falls if the medication causes dizziness or a sudden drop in blood pressure. Healthcare providers typically 'start low and go slow' when dosing Atenolol for seniors.
As Atenolol is almost entirely eliminated by the kidneys, patients with a Glomerular Filtration Rate (GFR) or Creatinine Clearance (CrCl) below 35 mL/min require significant dose reductions. Failure to adjust the dose can lead to drug accumulation and toxic effects, such as severe bradycardia. For those on hemodialysis, the drug is removed during the procedure, so a supplemental dose is often given afterward.
Because Atenolol undergoes minimal metabolism in the liver, it is generally considered safe for patients with liver disease (Child-Pugh Class A, B, or C). No specific dose adjustments are typically required, making it a preferred beta-blocker for patients with cirrhosis or hepatitis compared to lipophilic blockers like propranolol.
> Important: Special populations require individualized medical assessment. Always inform your doctor if you are planning to become pregnant or have known kidney issues.
Atenolol is a 'cardioselective' beta-1 adrenergic antagonist. Its primary site of action is the beta-1 receptors located on the myocardium (heart muscle) and in the conduction system of the heart. By binding to these receptors, Atenolol prevents the activation of the G-protein-coupled receptor pathway that normally leads to the production of cyclic adenosine monophosphate (cAMP). Lower levels of cAMP result in decreased calcium influx into the heart cells, which reduces the force of contraction and slows the heart's internal 'pacemaker' (the SA node). At higher doses, Atenolol's selectivity decreases, and it may begin to block beta-2 receptors in the bronchial and vascular smooth muscle.
The onset of action for oral Atenolol is approximately 1 hour, with the maximum effect occurring between 2 and 4 hours. The duration of action is significantly longer than its half-life would suggest, often lasting 24 hours, which is why once-daily dosing is effective for hypertension. It does not possess membrane-stabilizing activity or intrinsic sympathomimetic activity, making it a 'pure' blocker.
| Parameter | Value |
|---|---|
| Bioavailability | 40% to 50% |
| Protein Binding | 6% to 16% (Low) |
| Half-life | 6 to 7 hours |
| Tmax | 2 to 4 hours |
| Metabolism | Minimal (Hepatic) |
| Excretion | Renal (85% to 100% unchanged) |
Atenolol is classified as a Class II Antiarrhythmic and a cardioselective beta-adrenergic blocker. Related medications in the same class include metoprolol, bisoprolol, and betaxolol. It differs from non-selective blockers like propranolol or carvedilol, which block both beta-1 and beta-2 (and sometimes alpha) receptors.
Medications containing this ingredient
Common questions about Atenolol
Atenolol is primarily used to treat hypertension (high blood pressure) and angina pectoris (chest pain). By lowering blood pressure, it helps prevent serious complications such as strokes, heart attacks, and kidney problems. Additionally, it is used in the acute and long-term management of patients who have suffered a myocardial infarction (heart attack) to improve survival rates. Some doctors also prescribe it off-label for conditions like migraine prevention or to control physical symptoms of anxiety, such as a racing heart. It works by blocking the action of certain natural chemicals in your body, such as adrenaline, on the heart and blood vessels.
The most common side effects of Atenolol include fatigue, cold hands and feet, dizziness, and a slow heart rate. Because the medication reduces the workload of the heart, many patients feel a general sense of tiredness or lack of energy, especially when starting the drug. Dizziness often occurs when moving from a sitting to a standing position too quickly. Some people may also experience gastrointestinal upset, such as nausea or diarrhea. These symptoms are usually mild, but you should discuss them with your healthcare provider if they persist or become bothersome.
It is generally advised to limit or avoid alcohol while taking Atenolol. Alcohol can enhance the blood-pressure-lowering effects of the medication, which may lead to dangerously low blood pressure. This can result in symptoms like severe dizziness, lightheadedness, or even fainting. Furthermore, alcohol can sometimes interfere with the management of the underlying heart conditions for which Atenolol was prescribed. If you do choose to drink, it should be done in moderation and only after discussing it with your doctor to ensure it is safe for your specific health profile.
Atenolol is classified as FDA Pregnancy Category D, which means there is evidence of potential risk to the fetus. Studies have shown that Atenolol can cross the placenta and may lead to fetal growth restriction, resulting in babies that are smaller than expected at birth. Additionally, newborns whose mothers took Atenolol near the time of delivery may experience low heart rate and low blood sugar. Because of these risks, Atenolol is usually only prescribed during pregnancy if other, safer medications are not effective. If you are pregnant or planning to become pregnant, you must discuss alternative treatments with your healthcare provider.
For conditions like high blood pressure, you may start to see a reduction in your readings within 1 to 2 hours of taking the first dose. However, it can take up to one or two weeks of consistent daily use to reach the full therapeutic effect. For patients taking it for angina, the reduction in chest pain frequency may also take several days to become apparent. It is important to continue taking the medication exactly as prescribed, even if you do not feel an immediate difference. Your doctor will likely monitor your progress over the first few weeks to determine if the dosage needs adjustment.
No, you should never stop taking Atenolol suddenly. Doing so can cause a dangerous 'rebound' effect, leading to a rapid heart rate, severe chest pain, or even a heart attack, especially if you have underlying coronary artery disease. The FDA has a 'Black Box Warning' regarding this risk. If the medication needs to be discontinued, your doctor will provide a specific schedule to gradually taper the dose over one to two weeks. This allows your heart to adjust slowly and prevents serious cardiovascular complications. Always consult your healthcare provider before making any changes to your medication regimen.
If you miss a dose of Atenolol, take it as soon as you remember. However, if your next scheduled dose is less than 8 hours away, you should skip the missed dose and simply take your next dose at the regular time. Do not take two doses at once to make up for the missed one, as this can lead to an excessively slow heart rate or a dangerous drop in blood pressure. Consistency is key with beta-blockers, so using a pillbox or a phone reminder can help you stay on track. If you miss multiple doses, contact your doctor for advice.
Weight gain is a possible side effect of many beta-blockers, including Atenolol, though it is not universal for all patients. The weight gain is usually modest, typically around 2 to 4 pounds, and often occurs in the first few months of treatment. This can happen because the medication slows your metabolism or because the fatigue it causes leads to decreased physical activity. In some cases, weight gain may be a sign of fluid retention, which could indicate worsening heart failure. If you notice sudden or significant weight gain, or swelling in your legs and ankles, you should report it to your doctor immediately.
Atenolol can interact with many other medications, so it is vital to provide your doctor with a full list of everything you take. It can have serious interactions with certain calcium channel blockers like verapamil or diltiazem, which can dangerously slow the heart. It may also interact with digoxin, clonidine, and even common over-the-counter NSAIDs like ibuprofen, which can reduce Atenolol's effectiveness. Diabetic medications may also need adjustment because Atenolol can mask the signs of low blood sugar. Your pharmacist can check for specific drug-drug interactions to ensure your combination of medications is safe.
Yes, Atenolol is widely available as a generic medication and is typically very affordable. The brand name version, Tenormin, is also available but is less commonly prescribed now that high-quality generic versions are on the market. Generic Atenolol is required by the FDA to have the same active ingredient, strength, and effectiveness as the brand-name drug. Because it is a common medication, it is stocked by almost all retail pharmacies. Using the generic version is an effective way to manage your condition while keeping healthcare costs low.